Development and Implementation of a Smoking Cessation Clinic in Community Pharmacy Practice
Journal of the American Pharmaceutical Association (1996)Published 1 January 2002
Daniel Kennedy, Ralph E. Small
Citations37
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The process and materials developed for this demonstration project can serve as templates for other pharmacy faculty members and community pharmacists who wish to offer smoking cessation clinics.
Abstract
The process and materials developed for this demonstration project can serve as templates for other pharmacy faculty members and community pharmacists who wish to offer smoking cessation clinics.
Keywords
MedicineHealth Professions
British Journal of AddictionThe Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
10,770 Citations1991Todd F. Heatherton, Lynn T. Kozlowski +2 more
A revision of the FTQ: the Fagerström Test for Nicotine Dependence (FTND), which found that a revised scoring of time to the first cigarette of the day (TTF) and number of cigarettes smoked per day (CPD) improved the scale.
New England Journal of MedicineA Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation
1,601 Citations1999Douglas E. Jorenby, Scott J. Leischow +10 more
Treatment with sustained-release bupropion alone or in combination with a nicotine patch resulted in significantly higher long-term rates of smoking cessation than use of either the nicotine patch alone or placebo.
New England Journal of MedicineA Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
1,266 Citations1997R. Douglas Hurt, David P.L. Sachs +10 more
A double-blind, placebo-controlled trial of a sustained-release form of bupropion for smoking cessation, which excluded smokers with current depression, but not those with a history of major depression.
Journal of the American Academy of Nurse PractitionersTreating Tobacco Use and Dependence
722 Citations2001Mary Jo Goolsby
JAMAThe Effectiveness of the Nicotine Patch for Smoking Cessation
338 Citations1994Michael C. Fiore
The pooled abstinence data showed that intensive behavioral counseling had a reliable but modest positive impact on quit rates, and the active patch was superior to the placebo patch regardless of patch type, patch treatment duration, weaning, counseling format, or counseling intensity.
Medical Entomology and ZoologyTextbook of Therapeutics: Drug and Disease Management
210 Citations1996Eric T. Herfindal, Dick R. Gourley
Medical Clinics of North AmericaCigarette smoking and nicotine addiction
152 Citations1992Neal L. Benowitz
Rational treatment of the pharmacologic aspects of tobacco addiction includes nicotine substitution therapy, and new formulations of nicotine substitutes will provide more options to the physician for tailoring treatment to the needs of individual smokers.
Archives of Internal MedicineCigarette Smoking, Nicotine Addiction, and Its Pharmacologic Treatment
67 Citations1993E. Lee
Nonpharmacologic modalities are briefly mentioned but play a major role in helping the smoker quit and the combination of nicotine substitution and clonidine may be useful but will need formal investigation.
Journal of the American Pharmaceutical Association (1996)Results of a Smoking Cessation Clinic in Community Pharmacy Practice
65 Citations2002Daniel Kennedy, Joel Giles +3 more
Compared with other types of previously reported interventions, a community pharmacist-managed smoking cessation clinic achieved greater long-term smoking cessation rates.
American Journal of Health BehaviorA Comparison of Sustained-release Bupropion and Placebo for Smokeless Tobacco Cessation
39 Citations2002Elbert D. Glover, Penny N. Glover +3 more
Bupropion SR appears to be effective for smokeless tobacco cessation in males in a double-blind, placebo-controlled 3-month trial.
American Journal of Health-System PharmacyPharmacy applications of the transtheoretical model in smoking cessation
32 Citations1995Karen Suchanek Hudmon, Bruce A. Berger
The transtheoretical model for intentional behavior change is described, and pharmacists' use of the model in smoking-cessation interventions is discussed, which combines elements of theories used in psychotherapy and behavior modification.
American Journal of Public HealthSmoking and life expectancy among U.S. veterans.
22 Citations1978Eugene Rogot
Journal of the American Pharmaceutical Association (1996)Smoking Cessation: Part 1-An Overview
5 Citations1998Supakit Wongvvivvatthananukit, Helen M. Jack +1 more
To assist the patient contemplating smoking cessation, the pharmacist must be able to assess the patient's level of motivation to quit smoking and must have the requisite social support skills and knowledge about habit changes the patient will have to acquire to be successful.